Revenue (Tables)

3 Months Ended

Dec. 26, 2020

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:


		Three Months Ended December 26, 2020
Business (in millions)		United States		International		Total
Diagnostics:
	Cytology & Perinatal	$	80.1	$	44.7	$	124.8
	Molecular Diagnostics	675.3		320.0		995.3
	Blood Screening	8.1		—		8.1
Total		$	763.5	$	364.7	$	1,128.2

Breast Health:
	Breast Imaging	$	203.0	$	64.7	$	267.7
	Interventional Breast Solutions	55.2		9.8		65.0

Total		$	258.2	$	74.5	$	332.7

GYN Surgical		$	101.0	$	23.0	$	124.0



Skeletal Health		$	15.1	$	9.8	$	24.9
		$	1,137.8	$	472.0	$	1,609.8


		Three Months Ended December 28, 2019
Business (in millions)			United States		International		Total
Diagnostics:
	Cytology & Perinatal		$	77.5	$	43.5	$	121.0
	Molecular Diagnostics		142.1		36.4		178.5
	Blood Screening		12.0		—		12.0
Total			$	231.6	$	79.9	$	311.5

Breast Health:
	Breast Imaging		$	209.4	$	65.4	$	274.8
	Interventional Breast Solutions		47.1		9.2		56.3

Total			$	256.5	$	74.6	$	331.1

GYN Surgical			$	98.8	$	20.3	$	119.1

Medical Aesthetics			$	30.9	$	34.4	$	65.3

Skeletal Health			$	14.9	$	8.6	$	23.5
			$	632.7	$	217.8	$	850.5


	Three Months Ended
Geographic Regions (in millions)	December 26, 2020		December 29, 2019
United States	$	1,137.8	$	632.7
Europe	338.2		109.4
Asia-Pacific	88.3		70.2
Rest of World	45.5		38.2
	$	1,609.8	$	850.5

The following table provides revenue recognized by source:


	Three Months Ended
Revenue by type (in millions)	December 26, 2020		December 28, 2019
Disposables	$	1,263.4	$	466.4
Capital equipment, components and software	192.0		232.9
Service	137.1		145.0
Other	17.3		6.2
	$	1,609.8	$	850.5